H.B. Fuller (FUL) Gets Higher Price Target from UBS on Earnings Optimism
Jun 23, 2026
UBS raised H.B. Fuller's price target to $71 citing earnings optimism, while JPMorgan upgraded the stock to Neutral referencing valuation and the Advanced Medical Solutions deal. The company retains its Dividend King status with a 5-year average dividend growth rate of 7.72%.
Show all 21 updates